Literature DB >> 20140170

Identification of adverse drug events: the use of ICD-10 coded diagnoses in routine hospital data.

Jürgen Stausberg1, Joerg Hasford.   

Abstract

BACKGROUND: Adverse drug events (ADE) are a common cause of hospital admission as well as a common complication of inpatient care. The current reporting systems in Germany are of only limited use for the identification of ADE. The aim of this study is to examine the potential usefulness of ICD-10 coded diagnoses in routine hospital data for the identification of ADE.
METHODS: The common, major manifestations of ADE were mapped to the ICD-10-GM, and categories in the ICD-10-GM for which a possible causal relationship with medications is explicitly mentioned were included as well. A total of 505 relevant ICD-10-GM codes were identified. An evaluation was carried out on the basis of an aggregated data set from eleven million inpatients treated in 2006.
RESULTS: 0.7% of hospital admissions were revealed by routine data to be causally related to the administration of a drug. In 5.3% of admissions, there was at least a reason to suspect such a causal relation. Furthermore, one of the 505 relevant codes was found to be present in 9.0% of the secondary diagnoses.
CONCLUSIONS: The available ICD-10-GM codes for manifestations of ADE are used in routine hospital data in Germany. Their usefulness for the identification of ADE should be better exploited. Our results and other relevant published literature imply that this procedure will result in both false-positive and false-negative findings, which will have to be taken into account as well.

Entities:  

Mesh:

Year:  2010        PMID: 20140170      PMCID: PMC2816787          DOI: 10.3238/arztebl.2010.0023

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN: 1866-0452            Impact factor:   5.594


  16 in total

1.  Adverse drug reaction monitoring--cost and benefit considerations. Part I: frequency of adverse drug reactions causing hospital admissions.

Authors:  N Muehlberger; S Schneeweiss; J Hasford
Journal:  Pharmacoepidemiol Drug Saf       Date:  1997-10       Impact factor: 2.890

2.  Measuring patient safety in ambulatory care: potential for identifying medical group drug-drug interaction rates using claims data.

Authors:  Leif I Solberg; Judith S Hurley; Melissa H Roberts; Winnie W Nelson; Floyd J Frost; A Lauren Crain; Margaret J Gunter; Linda R Young
Journal:  Am J Manag Care       Date:  2004-11       Impact factor: 2.229

3.  A methodological framework for the conversion of procedure classifications.

Authors:  J Stausberg; B Dahmen; S Drösler
Journal:  Methods Inf Med       Date:  2005       Impact factor: 2.176

4.  Hospital admissions for 'drug-induced' disorders in England: a study using the Hospital Episodes Statistics (HES) database.

Authors:  Patrick Waller; Mary Shaw; Davidson Ho; Saad Shakir; Shah Ebrahim
Journal:  Br J Clin Pharmacol       Date:  2005-02       Impact factor: 4.335

5.  Repeat adverse drug reactions causing hospitalization in older Australians: a population-based longitudinal study 1980-2003.

Authors:  Min Zhang; C D'Arcy J Holman; David B Preen; Kate Brameld
Journal:  Br J Clin Pharmacol       Date:  2007-02       Impact factor: 4.335

6.  Strategies for detecting adverse drug events among older persons in the ambulatory setting.

Authors:  Terry S Field; Jerry H Gurwitz; Leslie R Harrold; Jeffrey M Rothschild; Kristin Debellis; Andrew C Seger; Leslie S Fish; Lawrence Garber; Michael Kelleher; David W Bates
Journal:  J Am Med Inform Assoc       Date:  2004-08-06       Impact factor: 4.497

7.  Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study.

Authors:  Sebastian Schneeweiss; Joerg Hasford; Martin Göttler; Annemarie Hoffmann; Ann-Kathrin Riethling; Jerry Avorn
Journal:  Eur J Clin Pharmacol       Date:  2002-06-12       Impact factor: 2.953

Review 8.  Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies.

Authors:  Chuenjid Kongkaew; Peter R Noyce; Darren M Ashcroft
Journal:  Ann Pharmacother       Date:  2008-07-01       Impact factor: 3.154

9.  How often are potential patient safety events present on admission?

Authors:  Robert L Houchens; Anne Elixhauser; Patrick S Romano
Journal:  Jt Comm J Qual Patient Saf       Date:  2008-03

10.  Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes.

Authors:  Emma C Davies; Christopher F Green; Stephen Taylor; Paula R Williamson; David R Mottram; Munir Pirmohamed
Journal:  PLoS One       Date:  2009-02-11       Impact factor: 3.240

View more
  18 in total

1.  [Geriatric multimorbidity in claims data - part 2 : diagnoses of hospitals and diagnoses from physicians in the ambulatory setting].

Authors:  M Meinck; N Lübke; F Ernst
Journal:  Z Gerontol Geriatr       Date:  2012-10       Impact factor: 1.281

2.  Epidemiology of clostridium difficile infection.

Authors:  Jürgen Stausberg
Journal:  Dtsch Arztebl Int       Date:  2015-05-08       Impact factor: 5.594

Review 3.  Systemic review on drug related hospital admissions - A pubmed based search.

Authors:  Kolli Nivya; Vempati Sri Sai Kiran; Nandita Ragoo; B Jayaprakash; M Sonal Sekhar
Journal:  Saudi Pharm J       Date:  2013-05-30       Impact factor: 4.330

4.  JADE: a tool for medical researchers to explore adverse drug events using health claims data.

Authors:  D Edlinger; S K Sauter; C Rinner; L M Neuhofer; M Wolzt; W Grossmann; G Endel; W Gall
Journal:  Appl Clin Inform       Date:  2014-07-09       Impact factor: 2.342

5.  Utility of a Computerized ICD-10 Algorithm to Identify Idiosyncratic Drug-Induced Liver Injury Cases in the Electronic Medical Record.

Authors:  Amoah Yeboah-Korang; Jeremy Louissaint; Irene Tsung; Sharmila Prabhu; Robert J Fontana
Journal:  Drug Saf       Date:  2020-04       Impact factor: 5.606

6.  Hospitalizations and deaths related to adverse drug events worldwide: Systematic review of studies with national coverage.

Authors:  Lunara Teles Silva; Ana Carolina Figueiredo Modesto; Rita Goreti Amaral; Flavio Marques Lopes
Journal:  Eur J Clin Pharmacol       Date:  2021-10-30       Impact factor: 2.953

7.  Epidemiology of drug hypersensitivity reactions using 6-year national health insurance claim data from Korea.

Authors:  JaeEun Han; Young-Min Ye; Sukhyang Lee
Journal:  Int J Clin Pharm       Date:  2018-04-02

8.  Drug-related admissions and hospital-acquired adverse drug events in Germany: a longitudinal analysis from 2003 to 2007 of ICD-10-coded routine data.

Authors:  Jürgen Stausberg; Joerg Hasford
Journal:  BMC Health Serv Res       Date:  2011-05-29       Impact factor: 2.655

9.  International prevalence of adverse drug events in hospitals: an analysis of routine data from England, Germany, and the USA.

Authors:  Jürgen Stausberg
Journal:  BMC Health Serv Res       Date:  2014-03-13       Impact factor: 2.655

Review 10.  ICD-10 codes used to identify adverse drug events in administrative data: a systematic review.

Authors:  Corinne M Hohl; Andrei Karpov; Lisa Reddekopp; Mimi Doyle-Waters; Jürgen Stausberg
Journal:  J Am Med Inform Assoc       Date:  2013-11-12       Impact factor: 4.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.